Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
- Romain Guièze
- , Pauline Robbe
- , Ruth Clifford
- , Sophie De Guibert
- , Bruno Pereira
- , Adele Timbs
- , Marie Sarah Dilhuydy
- , Maite Cabes
- , Loïc Ysebaert
- , Adam Burns
- , Florence Nguyen-Khac
- , Frédéric Davi
- , Lauren Véronèse
- , Patricia Combes
- , Magali Le Garff-Tavernier
- , Véronique Leblond
- , Hélène Merle-Béral
- , Reem Alsolami
- , Angela Hamblin
- , Joanne Mason
- CHU de Clermont-Ferrand
- Université Clermont Auvergne
- John Radcliffe Hospital
- CHU de Rennes
- Bordeaux University Hospitals
- CHU de Toulouse
- Assistance publique – Hôpitaux de Paris
- Liverpool University Hospitals NHS Foundation Trust
- Leeds Teaching Hospitals NHS Trust
- University of Oxford
Research output: Contribution to journal › Article › peer-review